Atlas Trials

Study of Inhaled DMC-IH1 and Intramuscular (EpiPen®) Epinephrine in Healthy Male and Female Participants.

Clinical trial NCT06013150 · COMPLETED

Trial details

NCT number
NCT06013150
Sponsor
De Motu Cordis
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anaphylactic Reaction
Start date
2023-10-24
Primary completion
2023-12-15
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.